Search

Vexal-A

Vexal-A

anastrozole

Manufacturer:

Vexxa Lifesciences

Distributor:

VE Pharma
Concise Prescribing Info
Contents
Anastrozole
Indications/Uses
Treatment of breast cancer in postmenopausal women.
Click to view Vexal-A detailed prescribing information
Dosage/Direction for Use
1 tab once daily.
Click to view Vexal-A detailed prescribing information
Overdosage
View Vexal-A overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Premenopausal women. Pregnancy.
Click to view Vexal-A detailed prescribing information
Special Precautions
Monitor for reduced bone mineral density. Patients w/ or at risk of osteoporosis should have their bone density assessed at the start of therapy & at regular intervals thereafter.
Click to view Vexal-A detailed prescribing information
Adverse Reactions
GI disturbances including anorexia, nausea, vomiting, diarrhea, asthenia, hot flushes, dizziness, drowsiness, headache & rash.
Click to view Vexal-A detailed prescribing information
Storage
View Vexal-A storage conditions for details to ensure optimal shelf-life.
Description
View Vexal-A description for details of the chemical structure and excipients (inactive components).
Action
View Vexal-A mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02BG03 - anastrozole ; Belongs to the class of enzyme inhibitors. Used in treatment of neoplastic diseases.
Presentation/Packing
Form
Vexal-A FC tab 1 mg
Packing/Price
30's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in